Mucosal and Plasma IgA from HIV-1-Exposed Uninfected Individuals Inhibit HIV-1 Transcytosis Across Human Epithelial Cells1

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Journal of Immunology

• Publication date

  2000-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4049/jimmunol.165.9.5170PMID 11046049
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CCR5-Reactive Antibodies in Seronegative Partners of HIV-Seropositive Individuals Down-Modulate Surface CCR5 In Vivo and Neutralize the Infectivity of R5 Strains of HIV-1 In Vitro1

  2000cited by this paper
• Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian–human immunodeficiency virus infection

  2000cited by this paper
• HIV-1-Specific Mucosal CD8+ Lymphocyte Responses in the Cervix of HIV-1-Resistant Prostitutes in Nairobi1

  2000cited by this paper
• HIV neutralizing IgA in exposed seronegative subjects recognise an epitope within the gp41 coiled-coil pocket.

  2000cited by this paper
• Mapping of B-cell epitopes in rabbits immunised with various gag antigens for the production of HIV-1 gag capture ELISA reagents.

  2000cited by this paper
• Broadly cross-reactive HIV-specific cytotoxic T-lymphocytes in highly-exposed persistently seronegative donors.

  1999cited by this paper
• Human immunodeficiency virus type 1 infection, mucosal immunity, and pathogenesis: comments and conference summary.

  1999cited by this paper
• Resistance to HIV-1 infection among highly exposed sex workers in Nairobi: what mediates protection and why does it develop?

  1999cited by this paper
• Virologic responses to a ritonavir--saquinavir-containing regimen in patients who had previously failed nelfinavir.

  1999cited by this paper
• Salivary sIgA response in HIV-1 infection.

  1999cited by this paper
• Subtypes of Human Immunodeficiency Virus Type 1 and Disease Stage among Women in Nairobi, Kenya

  1999cited by this paper
• Human immunodeficiency virus (HIV)-specific IgA and HIV neutralizing activity in the serum of exposed seronegative partners of HIV-seropositive persons.

  1999cited by this paper
• HIV-1-specific mucosal IgA in a cohort of HIV-1-resistant Kenyan sex workers.

  1999cited by this paper
• Human immunodeficiency virus type 1 infection, mucosal immunity, and pathogenesis and extramural research programs at the National Institutes of Health.

  1999cited by this paper
• Cellular immunity and target cell susceptibility in persons with repeated HIV-1 exposure.

  1999cited by this paper
• HIV-1 vaccine-induced immune responses which correlate with protection from SHIV infection: compiled preclinical efficacy data from trials with ten different HIV-1 vaccine candidates.

  1999cited by this paper
• Studies of human immunodeficiency virus type 1 mucosal viral shedding and transmission in Kenya.

  1999cited by this paper
• A role for mucosal immunity in resistance to HIV infection.

  1999cited by this paper
• Antirotavirus Immunoglobulin A Neutralizes Virus In Vitro after Transcytosis through Epithelial Cells and Protects Infant Mice from Diarrhea

  1998cited by this paper
• Detection of Human Immunodeficiency Virus Antibodies in Oral Fluids

  1998cited by this paper
• Intracellular neutralization of HIV transcytosis across tight epithelial barriers by anti-HIV envelope protein dIgA or IgM.

  1998cited by this paper
• Neutralization of rotavirus and recognition of immunologically important epitopes on VP4 and VP7 by human IgA

  1997cited by this paper
• HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals

  1997cited by this paper
• Transcytosis of infectious human immunodeficiency virus across a tight human epithelial cell line barrier

  1997cited by this paper
• Protective immunity against HIV infection: has nature done the experiment for us?

  1996cited by this paper
• Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya.

  1996cited by this paper
• Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection.

  1996cited by this paper
• Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells.

  1995cited by this paper
• Immune responses in HIV-exposed seronegatives: have they repelled the virus?

  1995cited by this paper
• Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8+ T Cells

  1995cited by this paper
• Mechanisms of HIV/SIV Mucosal Transmission

  1994cited by this paper
• Stimulation of transcytosis of the polymeric immunoglobulin receptor by dimeric IgA.

  1994cited by this paper
• MT-2 cell tropism as prognostic marker for disease progression in human immunodeficiency virus type 1 infection

  1994cited by this paper
• Transcytosis of the polymeric Ig receptor requires phosphorylation of serine 664 in the absence but not the presence of dimeric IgA.

  1993cited by this paper
• Human MoAbs produced from normal, HIV‐1‐negative donors and specific for glycoprotein gp 120 of the HIV‐1 envelope

  1992cited by this paper
• Symmetric infection of rotavirus on polarized human intestinal epithelial (Caco-2) cells

  1991cited by this paper
• HIV infection among lower socioeconomic strata prostitutes in Nairobi.

  1990cited by this paper
• Endocytosis in filter-grown Madin-Darby canine kidney cells

  1989cited by this paper
• A method of obtaining, processing, and analyzing human intestinal secretions for antibody content.

  1988cited by this paper
• Cell surface polarity in epithelia.

  1985cited by this paper
• Polymeric IgA is Complexed with Secretory Component (SC) on the Surface of Human Intestinal Epithelial Cells

  1978cited by this paper

• IgA-dependent cell phagocytosis of HIV-infected cells elicits cross-presentation to CD8+T cells and immune memory in effector monocytes.

  2025cites this paper
• Mucosal immunity in acute HIV: a review of recent work

  2025cites this paper
• Natural Resistance to HIV Infection: Role of Immune Activation

  2025cites this paper
• HIV-1 and IgA Antibodies: Interactions and implications

  2024cites this paper
• Particulate antigens administrated by intranasal and intravaginal routes in a prime-boost strategy improve HIV-specific TFH generation, high-quality antibodies and long-lasting mucosal immunity.

  2023cites this paper
• Resistencia natural a la infección por el VIH-1. Revisión sistemática de la literatura

  2023cites this paper
• Exploring Immunome and Microbiome Interplay in Reproductive Health: Current Knowledge, Challenges, and Novel Diagnostic Tools

  2023cites this paper
• Variable-heavy (VH) families influencing IgA1&2 engagement to the antigen, FcαRI and superantigen proteins G, A, and L

  2022cites this paper
• Natural Immunity against HIV-1: Progression of Understanding after Association Studies

  2022cites this paper
• Vaccine with bacterium‐like particles displaying HIV‐1 gp120 trimer elicits specific mucosal responses and neutralizing antibodies in rhesus macaques

  2022cites this paper
• Impact of Caveolin-Mediated Endocytosis on the Trafficking of HIV within the Colonic Barrier

  2022cites this paper
• Meta-analysis of HIV-1 vaccine elicited mucosal antibodies in humans

  2021cites this paper
• Engaging the ‘A’ Class Antibody: Variable-Heavy (VH) region influencing IgA1&2 engagement of FcαRI and superantigen proteins G, A, and L

  2021cites this paper
• The Importance of Regulation in Natural Immunity to HIV

  2021cites this paper
• Overt IL-32 isoform expression at intestinal level during HIV-1 infection is negatively regulated by IL-17A

  2021cites this paper
• Medroxyprogesterone Acetate (MPA) Enhances HIV-1 Accumulation and Release in Primary Cervical Epithelial Cells by Inhibiting Lysosomal Activity

  2021cites this paper
• An HIV-1 vaccine based on bacterium-like particles elicits env-specific mucosal immune responses.

  2020cites this paper
• Preclinical Efficacy of a Trivalent Human FcγRI-Targeted Adjuvant-Free Subunit Mucosal Vaccine against Pulmonary Pneumococcal Infection

  2020cites this paper
• Effect of Lactobacillus plantarum IS-10506 on blood lipopolysaccharide level and immune response in HIV-infected children

  2019cites this paper
• HIV and SIV in Body Fluids: From Breast Milk to the Genitourinary Tract.

  2019cites this paper
• HIV-1/SIV Humoral Responses in External Secretions

  2019cites this paper
• Natural Immunity to HIV is associated with Low BLyS/BAFF levels and low frequencies of innate marginal zone like CD1c+ B-cells in the genital tract

  2019cites this paper
• Anti‐chlamydia IgG and IgA are insufficient to prevent endometrial chlamydia infection in women, and increased anti‐chlamydia IgG is associated with enhanced risk for incident infection

  2019cites this paper
• Localized cyclical variations in immunoproteins in the female genital tract and the implications on the design and assessment of mucosal infection and therapies

  2018cites this paper
• HIV-1 Env and HLA-C interaction is crucial in modulating viral infectivity

  2018cites this paper
• HIV-1-Specific IgA Monoclonal Antibodies from an HIV-1 Vaccinee Mediate Galactosylceramide Blocking and Phagocytosis

  2018cites this paper
• Immune Responses to Retroviruses.

  2018cites this paper
• Characterization of HIV-1 gp120 antibody specificities induced in anogenital secretions of RV144 vaccine recipients after late boost immunizations

  2018cites this paper
• Human IgM monoclonal antibodies block HIV-transmission to immune cells in cervico-vaginal tissues and across polarized epithelial cells in vitro

  2018cites this paper
• Use of broadly neutralizing antibodies for HIV‐1 prevention

  2017cites this paper
• Humoral responses against HIV in male genital tract: role in sexual transmission and perspectives for preventive strategies.

  2017cites this paper
• Functional assessment on non-neutralizing binding antibodies in the blood and genital tracts of women with breakthrough HIV infection from the CAPRISA 004 1% tenofovir gel trial.

  2017cites this paper
• 10 HIV Envelope-Specific Antibody and Vaccine Efficacy

  2017cites this paper
• A Little Help From the Follicles: Understanding the Germinal Center Response to Human Immunodeficiency Virus 1 Infection and Prophylactic Vaccines

  2017cites this paper
• Sublingual Priming with a HIV gp41-Based Subunit Vaccine Elicits Mucosal Antibodies and Persistent B Memory Responses in Non-Human Primates

  2017cites this paper
• The Role of Natural Antibodies to CC Chemokine Receptor 5 in HIV Infection

  2017cites this paper
• A heterologous prime-boosting strategy with replicating Vaccinia virus vectors and plant-produced HIV-1 Gag/dgp41 virus-like particles

  2017cites this paper
• Antibody-Based Preventive and Therapeutic Strategies Against HIV.

  2016cites this paper
• Immunological Profile: CD4, CD8, HIV Cofactors and Viral Load in HIV Discordant Couples when Compared with Concordant Couples

  2016cites this paper
• Alteration of Polymeric Immunoglobulin Receptor and Neonatal Fc Receptor Expression in the Gut Mucosa of Immunodeficiency Virus‐Infected Rhesus Macaques

  2016cites this paper
• Immunological Characterization of Plant-Based HIV-1 Gag/Dgp41 Virus-Like Particles

  2016cites this paper
• Early short-term treatment with neutralizing human monoclonal antibodies halts SHIV infection in newborn macaques

  2016cites this paper
• Intradermal immunisation using the TLR3-ligand Poly (I:C) as adjuvant induces mucosal antibody responses and protects against genital HSV-2 infection

  2016cites this paper
• Broadly neutralizing antibodies suppress post-transcytosis HIV-1 infectivity

  2016cites this paper
• HIV-1-Neutralizing IgA Detected in Genital Secretions of Highly HIV-1-Exposed Seronegative Women on Oral Preexposure Prophylaxis

  2016cites this paper
• A HIV-Tat/C4-binding protein chimera encoded by a DNA vaccine is highly immunogenic and contains acute EcoHIV infection in mice

  2016cites this paper
• Mucosal vaccination with a live recombinant rhinovirus followed by intradermal DNA administration elicits potent and protective HIV-specific immune responses

  2016cites this paper
• Current Advances in Virus-Like Particles as a Vaccination Approach against HIV Infection

  2016cites this paper
• Searching for an hiv vaccine: a heterologous prime-boost system using replicating vaccinia virus and plant-produced virus-like particles

  2016cites this paper
• Immunity to Sexually Transmitted Infections

  2015cites this paper
• Mother-to-Child HIV-1 Transmission Events Are Differentially Impacted by Breast Milk and Its Components from HIV-1-Infected Women

  2015cites this paper
• Interactions between HIV, microorganisms and immune humoral factors in HIV-2 and HIV-1 infection

  2015cites this paper
• Exosomes in human semen restrict HIV-1 transmission by vaginal cells and block intravaginal replication of LP-BM5 murine AIDS virus complex.

  2015cites this paper
• New prospects for a preventive HIV-1 vaccine

  2015cites this paper
• Cross-protection against H7N9 influenza strains using a live-attenuated H7N3 virus vaccine.

  2015cites this paper
• Distinct genital tract HIV-specific antibody profiles associated with tenofovir gel

  2015cites this paper
• Biological Activities of IgA

  2015cites this paper
• Human/Simian Immunodeficiency Virus Transmission and Infection at Mucosal Sites

  2015cites this paper
• Biophysical Characterization of a Vaccine Candidate against HIV-1: The Transmembrane and Membrane Proximal Domains of HIV-1 gp41 as a Maltose Binding Protein Fusion

  2015cites this paper
• Tackling HIV: Genetic vs. Immune CCR5 targeting

  2014influential citation
• Recent progress in HIV vaccines inducing mucosal immune responses

  2014cites this paper
• Mucosal Correlates of Protection in HIV‐1‐Exposed Sero‐negative Persons

  2014cites this paper
• Mucosal immune defense

  2014cites this paper
• Pseudo-Mannosylated DC-SIGN Ligands as Potential Adjuvants for HIV Vaccines

  2014cites this paper
• Antibody B cell responses in HIV-1 infection.

  2014cites this paper
• A Comparative Proteomic Analysis of the Soluble Immune Factor Environment of Rectal and Oral Mucosa

  2014cites this paper
• Intranasal Administration of a Therapeutic HIV Vaccine (Vacc-4x) Induces Dose-Dependent Systemic and Mucosal Immune Responses in a Randomized Controlled Trial

  2014cites this paper
• Recombinant expression, purification, and biophysical characterization of the transmembrane and membrane proximal domains of HIV‐1 gp41

  2014cites this paper
• HIV Acquisition Is Associated with Increased Antimicrobial Peptides and Reduced HIV Neutralizing IgA in the Foreskin Prepuce of Uncircumcised Men

  2014influential citation
• How can we design better vaccines to prevent HIV infection in women?

  2014cites this paper
• HIV-1 Specific IgA Detected in Vaginal Secretions of HIV Uninfected Women Participating in a Microbicide Trial in Southern Africa Are Primarily Directed Toward gp120 and gp140 Specificities

  2014cites this paper
• Are anti-HIV IgAs good guys or bad guys?

  2014cites this paper
• Challenges in Mucosal HIV Vaccine Development: Lessons from Non-Human Primate Models

  2014cites this paper
• Nonneutralizing Functional Antibodies: a New “Old” Paradigm for HIV Vaccines

  2014cites this paper
• Transcytosis of HIV-1 through Vaginal Epithelial Cells Is Dependent on Trafficking to the Endocytic Recycling Pathway

  2014cites this paper
• Induction of Potent and Long-Lived Antibody and Cellular Immune Responses in the Genitorectal Mucosa Could be the Critical Determinant of HIV Vaccine Efficacy

  2014cites this paper
• Gut-Associated Lymphoid Tissue-Regulated Intestinal Barrier in HIV Infection

  2013cites this paper
• Report of the Cent Gardes HIV Vaccine Conference: The B-cell response to HIV. Part 2: Non-neutralizing antibodies: Fondation Mérieux Conference Center, Veyrier du Lac, France 5-7 November 2012.

  2013cites this paper
• ReceptorIgA with the Human Polymeric Ig Structural Requirements for the Interaction

  2013cites this paper
• Analysis of antibody neutralization specificities in human immunodeficiency virus type 2 infection

  2013cites this paper
• Fc receptor-mediated immune responses: new tools but increased complexity in HIV prevention.

  2013cites this paper
• Multi-Faceted Functions of Secretory IgA at Mucosal Surfaces

  2013cites this paper
• Développement d'anticorps monoclonaux humains de type IgA dirigés contre la partie C-terminale de la protéine d'enveloppe gp41 du VIH-1

  2013cites this paper
• Development of microanalysis tools for characterization of the humoral response to infections diseases

  2013cites this paper
• Mucosal immunity in human and simian immunodeficiency lentivirus infections

  2013cites this paper
• HIV-1 gp41 envelope IgA is frequently elicited after transmission but has an initial short response half-life

  2013cites this paper
• A Systems Biology Examination of the Human Female Genital Tract Shows Compartmentalization of Immune Factor Expression

  2013cites this paper
• Bovine papillomavirus-like particles presenting conserved epitopes from membrane-proximal external region of HIV-1 gp41 induced mucosal and systemic antibodies.

  2013cites this paper
• Mucosal Immune Regulation: Does it Help Thwart HIV?

  2013cites this paper
• Randomized Phase I: Safety, Immunogenicity and Mucosal Antiviral Activity in Young Healthy Women Vaccinated with HIV-1 Gp41 P1 Peptide on Virosomes

  2013cites this paper
• IgM Repertoire Biodiversity is Reduced in HIV-1 Infection and Systemic Lupus Erythematosus

  2013cites this paper
• Quantitative analysis of differentially expressed saliva proteins in human immunodeficiency virus type 1 (HIV-1) infected individuals.

  2013cites this paper
• Report of the Cent Gardes HIV Vaccine Conference: The B-cell Response to HIV. Part 1: Broadly Neutralizing Antibodies Fondation Mérieux Conference Center, Veyrier du Lac, France, 5-7 November 2012.

  2013cites this paper
• 51 – Human immunodeficiency virus vaccines

  2013cites this paper
• Impact of IgA Constant Domain on HIV-1 Neutralizing Function of Monoclonal Antibody F425A1g8

  2013cites this paper
• Two mucosal-parenteral schedules to coadminister a multiantigenic formulation against HIV-1 in Balb/c mice.

  2012cites this paper
• Host Genetics and Resistance to HIV-1 Infection

  2012cites this paper
• Evaluation of Heterologous Vaginal SHIV SF162p4 Infection Following Vaccination with a Polyvalent Clade B Virus-Like Particle Vaccine

  2012cites this paper
• IMMUNOGLOBULIN A IN CHILDREN: MODERN CONCEPTS OF ITS ANTI-INFLAMMATORY AND PROINFLAMMATORY EFFECTOR FUNCTIONS

  2012cites this paper
• CCL28 induces mucosal homing of HIV-1-specific IgA-secreting plasma cells in mice immunized with HIV-1 Virus-like Particles

  2012cites this paper